Report cover image

Global Acute Myeloid Leukemia (AML) Treatment Market: Forecast and Trends

Publisher BCC Research
Published Aug 18, 2023
Length 122 Pages
SKU # WA18141997

Description

Global Acute Myeloid Leukemia (AML) Treatment Market: Forecast and Trends



Report Scope:

This report aims to comprehensively study the market size of AML and treatments for a global market. Current and historical market revenues can be estimated based on treatment type, route of administration, end use, distribution channel and region.

Report Includes:

42 data tables and 57 additional tables

An overview of the global market for acute myeloid leukemia (AML) treatment

Analyses of global market trends, with data from 2020 to 2022, estimates for 2023 and projections of compound annual growth rates (CAGRs) through 2028

Highlights of the market potential and characterization of AML market based on treatment type, route of administration type, end-users, distribution channel, region

Coverage of various risk factors associated with AML, such as exposure to radiation or chemicals, genetic disorders, and weakened immune system

Description of major treatment options for AML such as, chemotherapy, targeted therapy, and stem cell transplantation

Information on recent mergers, acquisitions, collaborations, agreements, partnerships, product launches, and expansions in the market and a relevant patent analysis

Detailed company profiles of major players in the market of the industry, including AbbVie, Daiichi Sankyo, GlaxoSmithKline PLC, Pfizer Inc. and Servier

Companies Mentioned

ABBVIE
AMGEN INC.
ASTELLAS PHARMA INC.
BAYER AG
BIOGEN
BRISTOL MYERS SQUIBB
DAIICHI SANKYO CO. LTD.
GILEAD SCIENCES INC.
GLAXOSMITHKLINE PLC
MERCK & CO. INC.
NOVARTIS
PFIZER INC.
SANOFI
SERVIER LABORATORIES
TEVA PHARMACEUTICAL INDUSTRIES LTD.

Table of Contents

122 Pages
Table of Contents Chapter 1 Introduction Study Goals and Objectives Reasons for Doing This Study Scope of Report Methodology Information Sources Primary Research Secondary Research Geographic Breakdown Chapter 2 Summary and Highlights Market Outlook This Report Highlights Chapter 3 Market Overview and Definitions Overview Acute Myeloid Leukemia The Global Regulatory Structure for AML Pricing and Reimbursement for AML Therapies/Drugs to Treat AML FLT3 Inhibitors IDH Inhibitors Apoptosis Stimulants DNA Methylation Inhibitors DNA Intercalators Angiogenesis Inhibitors DNA Synthesis Inhibitors Chapter 4 Market Dynamics Market Drivers Growing Elderly Population Increasing Incidence and Prevalence Advancements in Molecular Diagnostics Minimal Residual Disease (MRD) Monitoring Gene Expression Profiling Fusion Gene Detection Liquid Biopsies R&D Regulatory Environment Personalized Medicine Collaborative Efforts Patient Advocacy and Awareness Market Opportunity Strategic Initiative Market Restraints High Costs Limited Treatment Options Treatment-related Toxicity and Adverse Effects Regulatory and Reimbursement Challenges Chapter 5 Impact of COVID-19 Introduction COVID-19 Impact on AML Treatments Chapter 6 Market Breakdown by Region Market Overview and Discussion North America Europe Asia-Pacific Rest of the World Chapter 7 Market Breakdown by Treatment Type Market Overview and Discussion Targeted Therapy Anthracycline Drugs Other Chemotherapies Targeted Therapy Anthracycline Drugs Other Chemotherapies Chapter 8 Market Breakdown by Route of Administration Market Overview and Discussion Intravenous (IV) Administration Oral Administration Intravenous (IV) Administration Chapter 9 Market Breakdown by Product FLT3 Inhibitors Apoptosis Stimulants Angiogenesis Inhibitors DNA Methylation Inhibitors DNA Synthesis Inhibitors DNA Intercalators Chapter 10 ESG Development Introduction Environment Governance Chapter 11 Emerging Trends and Technologies Introduction Chapter 12 Competitive Landscape Overview Industry Scenario Company Shares Chapter 13 Patent Analysis Patent Analysis by Manufacturer Chapter 14 Pipeline Analysis Clinical Trail Scenario Chapter 15 M&A and Venture Funding Outlook Introduction Chapter 16 Company Profiles ABBVIE AMGEN INC. ASTELLAS PHARMA INC. BAYER AG BIOGEN BRISTOL MYERS SQUIBB DAIICHI SANKYO CO. LTD. GILEAD SCIENCES INC. GLAXOSMITHKLINE PLC MERCK & CO. INC. NOVARTIS PFIZER INC. SANOFI SERVIER LABORATORIES TEVA PHARMACEUTICAL INDUSTRIES LTD. Chapter 17 Appendix: Acronyms

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us